↓ Skip to main content

Integration of Pharmaceutical Discovery and Development

Overview of attention for book
Cover of 'Integration of Pharmaceutical Discovery and Development'

Table of Contents

  1. Altmetric Badge
    Book Overview
  2. Altmetric Badge
    Chapter 1 Introduction
  3. Altmetric Badge
    Chapter 2 Renin Inhibitors
  4. Altmetric Badge
    Chapter 3 The Discovery and Development of Angiotensin II Antagonists
  5. Altmetric Badge
    Chapter 4 Development of an Orally Active Tripeptide Arginal Thrombin Inhibitor
  6. Altmetric Badge
    Chapter 5 Discovery and Development of an Endothelin a Receptor-Selective Antagonist PD 156707
  7. Altmetric Badge
    Chapter 6 Endothelin Receptor Antagonists
  8. Altmetric Badge
    Chapter 7 LHRH Antagonists
  9. Altmetric Badge
    Chapter 8 LHRH Agonists
  10. Altmetric Badge
    Chapter 9 Discovery and Development of Somatostatin Agonists
  11. Altmetric Badge
    Chapter 10 Factors Impacting the Delivery of Therapeutic Levels of Pyrone-Based HIV Protease Inhibitors
  12. Altmetric Badge
    Chapter 11 The Integration of Medicinal Chemistry, Drug Metabolism, and Pharmaceutical Research and Development in Drug Discovery and Development
  13. Altmetric Badge
    Chapter 12 De Novo Design and Discovery of Cyclic HIV Protease Inhibitors Capable of Displacing the Active-Site Structural Water Molecule
  14. Altmetric Badge
    Chapter 13 Discovery and Development of the BHAP Nonnucleoside Reverse Transcriptase Inhibitor Delavirdine Mesylate
  15. Altmetric Badge
    Chapter 14 Famciclovir
  16. Altmetric Badge
    Chapter 15 The Use of Esters as Prodrugs for Oral Delivery of β-Lactam Antibiotics
  17. Altmetric Badge
    Chapter 16 Hematoregulators
  18. Altmetric Badge
    Chapter 17 Discovery and Development of GG745, a Potent Inhibitor of Both Isozymes of of 5α-Reductase
  19. Altmetric Badge
    Chapter 18 Discovery of a Potent and Selective α 1A Antagonist
  20. Altmetric Badge
    Chapter 19 Discovery of Bioavailable Inhibitors of Secretory Phospholipase A 2
  21. Altmetric Badge
    Chapter 20 The Anxieties of Drug Discovery and Development
  22. Altmetric Badge
    Chapter 21 CI-1015
  23. Altmetric Badge
    Chapter 22 Orally Active Nonpeptide CCK-A Agonists
  24. Altmetric Badge
    Chapter 23 Orally Active Growth Hormone Secretagogues
  25. Altmetric Badge
    Chapter 24 Dorzolamide, a 40-Year Wait
  26. Altmetric Badge
    Chapter 25 Discovery and Development of Novel Melanogenic Drugs
Attention for Chapter 19: Discovery of Bioavailable Inhibitors of Secretory Phospholipase A 2
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
27 Dimensions

Readers on

mendeley
6 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Chapter title
Discovery of Bioavailable Inhibitors of Secretory Phospholipase A 2
Chapter number 19
Book title
Integration of Pharmaceutical Discovery and Development
Published in
Pharmaceutical biotechnology, January 2002
DOI 10.1007/0-306-47384-4_19
Pubmed ID
Book ISBNs
978-0-306-45743-2, 978-0-306-47384-5
Authors

Steven G. Blanchard, Robert C. Andrews, Peter J. Brown, Liang-Shang L. Gan, Frank W. Lee, Achintya K. Sinhababu, Thomas N. Wheeler, Blanchard, Steven G., Andrews, Robert C., Brown, Peter J., Gan, Liang-Shang L., Lee, Frank W., Sinhababu, Achintya K., Wheeler, Thomas N.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 6 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 6 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 2 33%
Student > Master 2 33%
Student > Doctoral Student 1 17%
Student > Ph. D. Student 1 17%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 3 50%
Chemistry 2 33%
Agricultural and Biological Sciences 1 17%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 August 2021.
All research outputs
#18,475,157
of 22,893,031 outputs
Outputs from Pharmaceutical biotechnology
#8
of 11 outputs
Outputs of similar age
#118,568
of 123,106 outputs
Outputs of similar age from Pharmaceutical biotechnology
#1
of 2 outputs
Altmetric has tracked 22,893,031 research outputs across all sources so far. This one is in the 11th percentile – i.e., 11% of other outputs scored the same or lower than it.
So far Altmetric has tracked 11 research outputs from this source. They receive a mean Attention Score of 2.4. This one scored the same or higher as 3 of them.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 123,106 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 2 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them